Category Archives: authorship issues
A pharmacy journal has retracted a 2017 cancer paper after determining that the lead author forged her co-author’s signature. Alain Li Wan Po, editor-in-chief of the Journal of Clinical Pharmacy and Therapeutics, told Retraction Watch that, after discovering the forgery, the journal lost confidence in “the integrity of the whole report,” and decided to retract […]
The post Journal retracts paper after discovering lead author forged co-author’s signature appeared first on Retraction Watch.
A journal has retracted a 2014 paper because of an authorship dispute that became the subject of litigation. Last year, the Allegheny Health Network in Pittsburgh requested the paper be retracted to resolve the dispute. The Journal of Applied Biomaterials & Functional Materials retracted the paper in October. According to the retraction notice, the principal […]
The post “The most terrible experience of my life:” Authorship dispute leads to lawsuit appeared first on Retraction Watch.
Carlo Croce, a cancer researcher who has faced numerous research misconduct allegations, recently accused a former lab member of misconduct. Although an institutional probe did not support that allegation, Croce’s efforts have led to a retraction. In November 2015, Croce and another cancer researcher at Ohio State University (OSU), Ramiro Garzon, contacted PLOS ONE, alleging […]
The post Carlo Croce, facing misconduct allegations, accuses former colleague of misconduct appeared first on Retraction Watch.
In 1980, Leila Tov-Ruach published a book chapter in which she thanked the editor of the book, Amélie Oksenberg Rorty, “for the hospitality that made the writing of this paper possible.” Normally, such an acknowledgement wouldn’t raise eyebrows. But, the trouble is, Tov-Ruach and Rorty are the same person: Leila Tov-Ruach is a pseudonym for […]
The post An accomplished philosopher invented a pseudonym. Why? appeared first on Retraction Watch.
At least one disgruntled co-author has triggered the retraction of a paper presenting a novel approach to treating a rare, genetically inherited condition. The paper concerned research on Fragile X syndrome (FXS), characterized by both intellectual and physical abnormalities, which is linked autism. A compound that passed through phase 2 clinical trials in October 2015 […]
The post Dispute over author order torpedoes paper on syndrome linked to autism appeared first on Retraction Watch.
In February 2016, Albert Jambon received some puzzling news. Several colleagues had alerted him to a paper, published online in late December 2015 in the Journal of African Earth Sciences (JAES), reporting the discovery of a rare mineral, which Jambon had been analyzing. When Jambon read the paper, he realized it was a modified version […]
The post Researcher discovers paper published by co-author in another journal appeared first on Retraction Watch.
Got $300? Then you can be added as an author to a paper — even if you had no role in the research. That’s right — some journals are willing to add authors to papers they didn’t write, often for a fee. This realization comes from one of the many sting experiments we’ve witnessed over […]
The post Authorship for sale: Some journals willing to add authors to papers they didn’t write appeared first on Retraction Watch.
A cell biology journal has retracted a 2016 paper after an investigation revealed that the corresponding author failed to include two co-authors and acknowledge the funding source. According to the retraction notice, the Journal of Cellular Physiology retracted the paper after the University of Texas, MD Anderson Cancer Center found that last author Jin Wang […]
The post Former MD Anderson researcher objects to retraction of his paper appeared first on Retraction Watch.